Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern

AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2015.0359
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance

AIDS
Infectious DiseasesAllergyImmunology
2011English

Minority Variants Associated With Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition Between HIV-1 Subtype B and Subtype a/E Infections

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism Comparison

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

F18, a Novel Small-Molecule Nonnucleoside Reverse Transcriptase Inhibitor, Inhibits HIV-1 Replication Using Distinct Binding Motifs as Demonstrated by Resistance Selection and Docking Analysis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor Through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy